The US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license application ...
Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback